Sihai network

Japan's capture of leukemia is false news. The truth is an expensive treatment

Japan's capture of leukemia is false news. The truth is an expensive treatment

Recently, an article about 'Japan conquering leukemia' was widely spread. The article said that Novartis pharmaceutical in Tokyo, Japan recently developed a drug called kymriah, which can treat leukemia.

In fact, kymriah is the trade name of a car-t therapy. The therapy was developed and sold by the research team of the University of Pennsylvania and Novartis in Switzerland as early as 2017. Gene manipulation requires cells to be transported to the United States.

The charge is as high as 33.49 million yen (about 2.27 million yuan). As the price is unbearable for ordinary people, Japan announced in May this year that kymriah was officially included in medical insurance, and the cost borne by patients was reduced to 410000 yen.